搜索结果91-100 的 823 / anti-TNF drugs

  1. 乳腺专科门诊- 临床试验- 妙佑医疗国际

    ... therapy medicines. Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of ...

  2. 乳腺专科门诊- 临床试验- 妙佑医疗国际

    ... therapy medicines. Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of ...

  3. 神经科- 临床试验- 妙佑医疗国际

    Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

  4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus ...

  5. 帕金森综合征- 症状与病因- 妙佑医疗国际

    帕金森病是一种渐进性疾病，会影响神经系统和受神经控制的身体部位。症状会慢慢出现。初始症状可能是不易察觉的单手震颤。除导致常见的震颤外，这种疾病还可能会导致动作 ...

  6. 脊柱保健- 临床试验- 妙佑医疗国际

    Jacksonville, Fla. The purpose of this study is to evaluate the utility, safety, effectiveness, and cost of physical therapy on elective spine surgery patients.

  7. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus ...

  9. 神经科- 临床试验- 妙佑医疗国际

    Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

  10. 神经科- 临床试验- 妙佑医疗国际

    Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...